Doctors Revision

Toxicology / Poisoning

Acetylsalicylic Acid (Aspirin) Poisoning

Poisoning due to excessive ingestion of acetylsalicylic acid (Aspirin) or other salicylates (e.g., methyl salicylate - oil of wintergreen). Toxicity is dose-dependent (>150mg/kg toxic, >300-500mg/kg severe) and causes complex metabolic disturbances including respiratory alkalosis and metabolic acidosis.

Also known as: Salicylate Poisoning, ASA Overdose, Aspirin Overdose

Open in the interactive guide
On this page

Referral and warning signs

When to refer

ALL patients with suspected significant salicylate poisoning require urgent referral to Hospital (H/RR). This includes symptomatic patients (beyond mild nausea), those with altered mental status, seizures, acidosis, hyperthermia, high levels, or requiring IV bicarbonate or haemodialysis. Refer patients with large or enteric-coated ingestions even if initially asymptomatic due to delayed absorption/toxicity.

Red flags

  • Altered mental status (confusion, lethargy, coma)
  • Seizures
  • Hyperthermia (>39-40°C)
  • Pulmonary edema (dyspnea, hypoxia, crackles on auscultation)
  • Severe or worsening metabolic acidosis
  • Serum salicylate level > 80-100 mg/dL (or rising rapidly)
  • Renal insufficiency
  • Clinical deterioration despite supportive care

Signs and symptoms

  • Early/Mild-Moderate (<300mg/kg): Hyperventilation (tachypnea - direct respiratory center stimulation), Tinnitus (ringing in ears), Hearing loss/muffled hearing, Vertigo/Dizziness, Nausea, Vomiting, Diaphoresis (sweating), Flushing, Lethargy or excitability.
  • Severe (>300-500mg/kg): Worsening hyperventilation, Marked lethargy progressing to confusion, agitation, delirium, coma, Seizures (especially in severe acidosis), Hyperthermia (due to uncoupling of oxidative phosphorylation), Non-cardiogenic pulmonary edema, Dehydration, Electrolyte abnormalities (hypokalemia common initially), Bleeding diathesis (less common in acute overdose), Severe metabolic acidosis (high anion gap), Hypoglycemia (especially in children).

Risk factors

  • Intentional overdose (suicide attempt).
  • Accidental ingestion (especially children).
  • Therapeutic overuse (chronic poisoning, often insidious, especially in elderly or those with renal impairment).
  • Use of topical salicylates (e.g., methyl salicylate) over large skin areas or under occlusion.
  • Ingestion of oil of wintergreen (highly concentrated methyl salicylate).

Diagnosis

Clinical assessment

Based on history of ingestion (type, amount, time - note delayed absorption with enteric-coated preps). Characteristic clinical features (tinnitus, hyperpnea, altered mental status, hyperthermia). Assessment of acid-base status is crucial.

Investigations

  • Serum Salicylate Level: Essential. Obtain level at presentation and serially every 2-4 hours until peaking and declining. Peak level may be delayed 4-6 hours or longer with enteric-coated or massive ingestions. Use Done nomogram for acute ingestions only (less reliable now, interpret level with clinical picture and acid-base status). Level >30mg/dL (2.2mmol/L) usually symptomatic; >80-100mg/dL (5.8-7.2mmol/L) often severe.
  • Arterial Blood Gas (ABG) or Venous Blood Gas (VBG with electrolytes): CRITICAL for assessing acid-base status (respiratory alkalosis, metabolic acidosis, mixed disorder) and guiding therapy (bicarbonate).
  • Electrolytes: Check potassium (often low), calculate anion gap (usually elevated in metabolic acidosis).
  • Blood Glucose: Check frequently, especially in children and those with altered mental status (risk of neuroglycopenia).
  • Renal Function Tests (Urea, Creatinine).
  • Complete Blood Count (CBC), Coagulation Studies (INR) - less common acute effects.
  • Urine pH: Monitor during alkaline diuresis.
  • Chest X-ray: Assess for pulmonary edema.

Diagnostic criteria

Clinical presentation consistent with salicylate toxicity + History of exposure + Elevated serum salicylate level + Characteristic acid-base disturbance (especially metabolic acidosis).

Management

Non-pharmacological management

  • Stabilization: ABCDE approach. Airway management if comatose/seizing. High-flow oxygen.
  • Fluid Resuscitation: Aggressive IV fluid resuscitation with isotonic crystalloids (e.g., Normal Saline, Ringer's Lactate) to correct dehydration, maintain renal perfusion, and aid elimination. Avoid fluid overload, especially if pulmonary edema suspected.
  • GI Decontamination:
  • - Activated Charcoal (Oral/NGT): Give ASAP (50g adult, 1g/kg child). Effective in reducing absorption.
  • - Multiple-Dose Activated Charcoal (MDAC): Consider 25-50g q4h. Enhances elimination by interrupting enterohepatic/enteric recirculation. Requires protected airway and bowel sounds.
  • - Gastric Lavage: May be considered if massive, life-threatening ingestion presenting within 1 hour (benefit uncertain vs risk). Salicylates delay gastric emptying, so potentially useful up to 4 hours per UCG (use cautiously).
  • Cooling Measures: Tepid sponging, cooling blankets for hyperthermia.
  • Avoid Intubation if Possible: Hyperventilation is compensatory; sedation/paralysis for intubation can worsen acidosis if ventilation not matched. If intubation necessary, maintain hyperventilation.
  • Enhanced Elimination (Hospital/RR): Haemodialysis: Most effective method for removal. Indications: Severe poisoning (high levels >80-100 mg/dL or >7.2mmol/L), Altered mental status (coma, seizures), Pulmonary edema, Renal failure, Severe/worsening acidosis unresponsive to bicarbonate, Clinical deterioration despite supportive care.

Pharmacological treatment

  • Glucose Supplementation: IV Dextrose to prevent/treat hypoglycemia and neuroglycopenia (brain may have low glucose despite normal serum levels). Add Dextrose to maintenance IV fluids.
  • Urinary Alkalinization: IV Sodium Bicarbonate: CRITICAL for moderate-severe poisoning. Enhances renal salicylate excretion and helps shift salicylate out of CNS. Indications: Symptomatic patients, significant metabolic acidosis, high salicylate levels. Regimen: Initial bolus 1-2 mEq/kg IV, followed by continuous infusion (e.g., 150 mEq NaHCO3 in 1L D5W, run at 1.5-2 times maintenance fluid rate). Target: Urine pH 7.5-8.5 AND Serum pH ~7.45-7.55. Requires: Close monitoring of urine pH, serum pH (ABG/VBG), serum electrolytes (especially Potassium - supplement K+ aggressively as needed, alkalosis worsens hypokalemia). Contraindicated in severe renal failure, pulmonary/cerebral edema.
  • Potassium Replacement: Correct hypokalemia aggressively (IV KCl), essential for effective alkaline diuresis.
  • Seizures: Treat with Benzodiazepines (Diazepam/Lorazepam) IV. Avoid phenytoin.

Monitoring

Frequent monitoring of: Vital signs (HR, BP, RR, Temp, SpO2), Mental status (GCS), Acid-base status (serial ABG/VBG), Serum electrolytes (esp. K+), Blood glucose, Renal function, Urine output and pH, Serial salicylate levels (until clearly falling and non-toxic). Monitor for pulmonary edema.

Complications

  • Severe metabolic acidosis
  • Non-cardiogenic pulmonary edema
  • Cerebral edema
  • Seizures, Status epilepticus
  • Coma
  • Hyperthermia
  • Acute kidney injury
  • Hypokalemia
  • Hypoglycemia/Neuroglycopenia
  • Bleeding (less common acutely)
  • Death

Prevention

  • Safe storage of medications, especially aspirin and products containing salicylates (e.g., oil of wintergreen).
  • Patient education on correct dosing and risks of overdose.
  • Awareness of salicylate content in various over-the-counter and topical products.
  • Use alternative analgesics/antipyretics where appropriate, especially in children (Reye's syndrome risk).
  • Mental health support for those at risk of intentional overdose.

Patient education

  • Explain the risks of salicylate overdose.
  • Reinforce safe medication storage.
  • Discuss the treatment plan, including need for monitoring and potential interventions like bicarbonate or dialysis.
  • If overdose was intentional, ensure psychiatric evaluation and follow-up are arranged.

Uganda-specific notes

Aspirin is still used, though less commonly than paracetamol. Management relies heavily on supportive care, fluids, MDAC, and careful IV bicarbonate therapy (if feasible). Haemodialysis availability is very limited. Early recognition of severity and prompt referral are key. Remember delayed gastric emptying allows for later utility of lavage/charcoal. Always check glucose. Aggressive potassium replacement is vital during alkalinization.

References

  • Uganda Clinical Guidelines (UCG) 2023

    Chapter 1, Section 1.3.4

Scroll to Top